Cargando…
European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432880/ https://www.ncbi.nlm.nih.gov/pubmed/25983659 http://dx.doi.org/10.1186/s12948-015-0010-3 |
| _version_ | 1782371550492622848 |
|---|---|
| author | Agostini, Carlo Canonica, Giorgio Walter Maggi, Enrico |
| author_facet | Agostini, Carlo Canonica, Giorgio Walter Maggi, Enrico |
| author_sort | Agostini, Carlo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4432880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44328802015-05-16 European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars Agostini, Carlo Canonica, Giorgio Walter Maggi, Enrico Clin Mol Allergy Editorial BioMed Central 2015-05-15 /pmc/articles/PMC4432880/ /pubmed/25983659 http://dx.doi.org/10.1186/s12948-015-0010-3 Text en © Agostini et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Editorial Agostini, Carlo Canonica, Giorgio Walter Maggi, Enrico European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title | European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title_full | European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title_fullStr | European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title_full_unstemmed | European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title_short | European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| title_sort | european medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432880/ https://www.ncbi.nlm.nih.gov/pubmed/25983659 http://dx.doi.org/10.1186/s12948-015-0010-3 |
| work_keys_str_mv | AT agostinicarlo europeanmedicinesagencyguidelineforbiologicalmedicinalproductsafurtherstepforasafeuseofbiosimilars AT canonicagiorgiowalter europeanmedicinesagencyguidelineforbiologicalmedicinalproductsafurtherstepforasafeuseofbiosimilars AT maggienrico europeanmedicinesagencyguidelineforbiologicalmedicinalproductsafurtherstepforasafeuseofbiosimilars |